Merck KgaA Cautious on Outlook as Profits Fall
Wall Street Journal
Germany’s Merck warned of negative impacts this year including likely declining Covid-19-related sales and chip market uncertainty, as it reported lower first-quarter earnings and targeted Ebitda pre in the range of €6.1-€6.7 billion